EU invests €35m into AI cancer diagnostics

The European Commission has pledged €35 million ($39.2 million) to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence (AI).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia

Insilico Medicine signs $200m AI drug discovery deal

10 October 2019 Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.

Big Pharma

UK life sciences partnership to use AI in disease detection

5 December 2018 The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.

Americas

Chinese company fund invests in AI specialist

13 June 2018 China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

EU invests €35m into AI cancer diagnostics

More on this story

Editor's picks

Editor's picks

More features